Dana McSherry is the Boston lead of McDermott Will & Schulte’s Litigation Practice Group and co-leads the firm’s False Claims Act (FCA) practice. She advises healthcare and life sciences companies in criminal and civil government enforcement matters and in related civil litigation, including civil False Claims Act (FCA) litigation. Dana guides clients through all aspects of civil and criminal investigations relating to Medicare and Medicaid billing and other government contracting issues, including negotiating with the government and managing clients’ responses to civil investigative demands and large-scale investigative subpoenas. She also assists clients in conducting internal investigations and counsels clients across the healthcare industry on compliance and risk management issues.
- Representing pharmaceutical company in state and federal investigations relating to patient support services
- Represented pharmaceutical company in industry-wide investigation by the US Attorney’s Office in Massachusetts and the DOJ into donations to charitable assistance foundations that provide financial assistance to Medicare patients
- Successfully defended a pharmacist charged with RICO, mail fraud, and Food, Drug and Cosmetics Act violations; following a two-month trial, the client was acquitted of all charges
- Best Lawyers in America, Healthcare Law (2023-2027), Criminal Defense: White-Collar, Litigation – Health Care, 2026-2027
- Thomson Reuters, Stand-out Lawyer – independently rated lawyers, 2025-2026
- Chambers USA, Litigation: White-Collar Crime & Government Investigations, 2025-2026
- Boston Bar Association
- Women’s Bar Association
- Boston College Law School, JD
- University of Notre Dame, BA, magna cum laude
- Massachusetts
- US District Court for the District of Massachusetts

Laura McLane
Laura McLane co-leads McDermott’s white-collar and government investigations practice as well as the Firm’s False Claims Act (FCA) practice, and is a nationally renowned FCA litigator. For over 25 years, Laura has defended companies touching all aspects of the healthcare and life sciences industries in government investigations, qui tam litigation under the FCA, and related matters. Clients call Laura “an exquisite lawyer, very smart and incisive,” a “fierce advocate for her clients,” and “simply a brilliant attorney with a tremendous ability to navigate difficult circumstances.” (Chambers USA). Laura was named Boston’s Lawyer of Year in Healthcare Litigation by Best Lawyers in America for 2025-2026.
- Represented the defendant in the groundbreaking Escobar case during which Laura obtained a writ of certiorari from the United States Supreme Court, after which the Court unanimously reversed an adverse decision of the court of appeals in the most important FCA decision in decades
- Defends healthcare providers and other healthcare entities spanning all sectors, such as hospitals, ambulatory surgery centers, laboratories, urgent care, emergency medicine, telemedicine, dentistry, dialysis, behavioral health, as well as medical device manufacturers, pharmaceutical manufacturers, healthcare investors, Medicare Advantage brokers, and others in government investigations and qui tam litigation under the False Claims Act and related statutes, including the Anti-Kickback Statute and the Stark Law
- Successfully advocated on behalf of numerous clients in persuading the government to decline to intervene or pursue claims under the FCA and related statutes
- Chambers USA, Litigation: White-Collar Crime & Government Investigations, 2021-2026 and Nationwide: False Claims Act, 2026
- Legal 500 US, 2020-2025
- Best Lawyers in America, Lawyer of the Year: Litigation – Healthcare, 2025-2026
- Best Lawyers in America, Healthcare Law, Litigation – Healthcare (2019-2027), Criminal Defense: White-Collar, 2027
- Who’s Who Legal: Healthcare, 2021
- Boston University School of Law, JD, cum laude
- Emory University, BA
- Massachusetts
- Supreme Court of the United States
- US Court of Appeals for the First Circuit
- US Court of Appeals for the Second Circuit
- US Court of Appeals for the Fifth Circuit
- US District Court for the District of Massachusetts
- US Court of Appeals for the Ninth Circuit
- US Court of Appeals for the Eleventh Circuit
- US District Court for the District of Colorado

Sarah Kitchell
Sarah Kitchell focuses her practice on transactional and regulatory matters affecting a wide range of clients in the health care industry, including nonprofit and for-profit health systems, academic medical centers, community hospitals, drug and device manufacturers, contract research organizations, and post-acute and sub-acute providers such as home health and hospice providers, therapy providers, behavioral health providers and senior living facilities.
- Served as co-counsel on multiple physician-alignment transactions involving large physician groups and health systems, as well as joint ventures for the development and implementation of urgent care and ambulatory surgery centers
- Served as legal counsel in the creation of a contract research organization from the ground up, including legal formation, assessment of conflict of interest issues, and drafting and negotiation of agreements with research sponsors, research sites and service providers
- Served on the transaction team for multiple community-hospital deals in the for-profit and nonprofit space
- Best Lawyers in America, Healthcare Law, 2021-2027
- Thomson Reuters, Stand-out Lawyer – independently rated lawyers, 2024-2026
- Boston Magazine, Top Lawyers in Healthcare Law, 2025
- Boston University School of Law, Dr. John Ordronaux Prize for greatest overall professional ability
- American Health Lawyers Association
- Boston Bar Association, Health Law and Tax Exempt Organization sections
- Boston University School of Law, JD, magna cum laude
- Stanford University, BA, with honors and distinction, Phi Beta Kappa
- Massachusetts

Elisabeth Moseley
Elisabeth Moseley focuses on cross-border mergers and acquisitions in the oil & gas and mining sectors. She has extensive experience of advising on share and asset acquisitions and divestments, group reorganisations, corporate finance, private equity investments, production sharing arrangements, joint ventures, joint operating agreements and commercial contracts.
- Advised Petrobras on the sale of its interests in Block BC-10 in the Campos Basin, Brazil for USD 1.54 billion*
- Advised Sasol on its acquisition of an interest in the Beetaloo unconventional acreage, Northern Territory, Australia*
- Advised New Age on the acquisition of an operated interest in the Etinde permit, Cameroon*
- IFLR1000, M&A, 2022-2023
- Legal 500 UK, Recommended, 2020, 2025-2026
- The M&A Advisor, “M&A Deal of the Year” International M&A Award Winner, 2019
- United Kingdom Energy Lawyers Group, Member
- Association of International Petroleum Negotiators, Member
- Australian Mining and Petroleum Law Association, Member
- BPP Law School, LPC, Modern History
- BPP Law School, PgDL
- University of Oxford, MA
- England and Wales
- English
- French

Sharon Lamb
Leads McDermott’s UK Health and Life Sciences Practice Group
Advises on global M&A and joint ventures across health services, pharma and life sciences, digital health, and health technologies
Counsels UK and international clients on NHS and public law procurement, regulatory, and contracting matters, including reimbursement and market access
Advises strategic and private equity investors on transactions and investments in health and life sciences
Sharon Lamb focuses her practice on transactional and regulatory advice in the health and life sciences sector and leads the firm’s UK Health and Life Sciences Practice Group.
Sharon advises on global transactional mandates, including mergers and acquisitions and joint ventures in health services, pharma and life sciences, digital health, and health technologies. She also provides strategic, regulatory, and commercial support to UK and international clients on UK health and life sciences matters, with a focus on health services, pharmaceuticals, medical devices, digital health, and health data.
- Advising several leading independent sector healthcare providers in the United Kingdom on strategic and regulatory matters with respect to the rights of patients to access NHS services, the rights of patients to choose their NHS providers and market access and reimbursement provisions and regulatory investigations
- Advised Sycamore Partners, a leading New York-based private equity firm, as UK healthcare regulatory counsel on its acquisition of Walgreens Boots Alliance, Inc. The total transaction is valued at up to $23.7 billion
- Represented Northwestern Memorial Healthcare (Northwestern) a leading U.S. based academic healthcare organization, in its partnership with The London Clinic Limited (TLC), the UK’s largest independent charitable hospital
Regulatory, Procurement and Privacy
- Advising multiple healthcare, software and IT providers on procurement disputes and procurement litigation with respect to the award of NHS contracts for services and supplies.
- Advising healthcare and life sciences companies on NHS market access, and contracting, including for the provision of healthcare services under NHS procurement and choice regimes.
- Chambers UK, Band 1 in Healthcare: Regulatory, 2020-2027; Healthcare: Corporate/Commercial, 2024-2027; Life Sciences: Regulatory, 2026-2027
- Legal 500 UK, Leading Partner, Life Sciences and Healthcare, 2017-2027
- The Best Lawyers in the United Kingdom, Healthcare Law, 2023-2025
- Who’s Who Legal: Healthcare 2021
- McDermott Will & Schulte, UK Health and Life Sciences Practice Group, leader
- Association of British HealthTech Industries (ABHI), Board of Directors, member
- University of Cape Town, LLB
- University of Cape Town, BCom
- England and Wales
- English

Bobbi J. Bierhals
Bobbi J. Bierhals has built her practice by developing creative and customized solutions for her clients. Her experience centers on tax and business planning for high-net-worth individuals and families. Her clients range from executives and first-generation entrepreneurs to multi-generational families, with net worth from $100 million to many billions of dollars, and include a number of individuals listed in the Forbes 400.
Bobbi’s breadth of experience across a wide range of client profiles enables her to help them identify and structure tax-advantageous structures for transferring wealth and business interests to younger generations. While many other estate planners focus almost exclusively on tax issues, Bobbi takes a holistic approach that balances tax and family considerations to fit each individual client’s goals. With a geographically diverse client base spanning the United States, Bobbi adeptly navigates the nuances of local law while addressing broader federal tax considerations.
- Structured a new family office for a client following the multibillion-dollar sale of the family business, including innovative structures that provided tax efficiency and administrative ease for the family office’s investment partnerships
- Formed a private trust company to provide much-needed flexibility for the future governance of a multibillion-dollar family trust
- Identified and implemented solutions for a client faced with the possibility that her unborn child conceived through artificial insemination may not qualify as a beneficiary of family trusts
- Chambers High Net Worth, Illinois: Private Wealth Law, 2019-2026
- Best Lawyers in America, Trusts and Estates, 2019–2027
- American College of Trust & Estate Counsel (ACTEC)
- Law & Politics, Illinois Rising Star
- American Bar Association
- Chicago Estate Planning Council
- A member of the American College of Trust and Estate Counsel (ACTEC)
- Harvard Law School, JD, cum laude
- University of Pennsylvania, BA, summa cum laude, Phi Beta Kappa
- Illinois
- Texas
- Wisconsin
- Wyoming
- US Tax Court
- US District Court – Northern District of Illinois

Catherine A. Battin
Catherine (Cate) A. Battin is the head of McDermott Will & Schulte’s State & Local Tax Practice Group and has practiced at the firm for more than 20 years.
Cate represents clients in all aspects of state and local tax matters, including controversies at the audit, administrative, and judicial levels across several jurisdictions. She advises on national state tax strategies involving a broad range of issues, such as income tax apportionment, sourcing, nexus, transfer pricing, combination and sales tax characterization of products and services, and other local excise tax issues. She has a particular focus on state and local tax controversies and has litigated cases throughout the United States, successfully arguing cases before state appellate and supreme courts.
- Successfully represented a major oil company in its case against the Cook County Department of Revenue at the Supreme Court of Illinois related to the taxability of bookout transactions under the county’s motor fuel tax
- Obtained a favorable ruling from the Supreme Court of South Carolina on behalf of two durable medical equipment suppliers that a state law unconstitutionally discriminates against interstate commerce in violation of the US Constitution’s dormant Commerce Clause
- Obtained a ruling of first impression from the Supreme Court of Illinois on behalf of a retailer on the issue of whether a private whistleblower firm is entitled to recovery of attorneys’ fees for serving on its own behalf
- Chambers USA, Tax: Controversy, 2024-2026
- Best Lawyers in America, Tax Law, 2018-2027
- Legal 500 US, 2021, 2022 and 2024–2025
- Thomson Reuters, Stand-out Lawyer – independently rated lawyers, 2025-2026
- International Tax Review, World Tax, 2016-2026
- Law & Politics, Rising Star, 2009
- Taxpayers’ Federation of Illinois, board of trustees
- Chicago Bar Association, chair of State & Local Tax Committee, 2013 to 2014
- Chicago-Kent College of Law, LLM, Taxation, with honors
- DePaul University College of Law, JD
- Lake Forest College, BA
- Illinois
- US District Court for the Northern District of Illinois
- English

Sarah Chapin Columbia
Serves as lead trial counsel in patent infringement, trade secrets, and invalidity litigation across multiple federal jurisdictions
Counsels clients on overall intellectual property strategy and positioning, including litigation avoidance
Provides strategic IP guidance in complex transactions where intellectual property assets are critical to the deal
Advises clients across pharma/biotech, internet, semiconductor, hardware and software, medical device, and manufacturing industries
Sarah Chapin Columbia is a Fellow of the American College of Trial Lawyers. Over the last dozen years, she has led 17 patent infringement, trade secrets, and invalidity trials (11 jury trials and six bench trials) across several jurisdictions, including the federal courts in Massachusetts, Florida, Delaware, Colorado, California, and Texas.
- Lead counsel for Alnylam in ongoing patent infringement litigation involving the cationic lipids essential to the delivery of the COVID-19 vaccines (Alnylam v. Pfizer/BionTech (D. Delaware); Alnylam v. Moderna (D. Delaware))
- Lead counsel for Next Caller in simultaneous patent infringement litigation and trade secrets, tortious interference and breach of contract litigation related to authentication services. Successfully secured a unanimous jury verdict in favor of Next Caller in both matters (TrustID Inc. v. Next Caller Inc., (D. Delaware), TRUSTID, Inc. v. Next Caller Inc., (D. Colorado))
- Lead counsel for Amgen in a patent infringement action and jury trials involving breakthrough biologic therapy for the treatment of high LDL cholesterol (Amgen v. Sanofi, et al., (D. Delaware))
- LMG Life Sciences, Shortlisted, General Patent Litigator of the Year – New England – 2026
- Chambers USA, Intellectual Property, Band 1 (Massachusetts) and Band 3 (Nationwide), 2008-2026; Life Sciences, Band 3 (Massachusetts), 2026
- The Best Lawyers in America, Lawyer of the Year in Boston: Litigation – Intellectual Property, 2022 and 2024-2026
- The Sedona Conference®, Working Group on Patent Damages and Remedies
- Harvard Law School, JD, magna cum laude
- Harvard University, MPP
- Wesleyan University, BA, Economics
- Massachusetts
- Supreme Court of the United States
- US Court of Appeals for the Federal Circuit
- US Court of Appeals for the First Circuit
- US Court of Appeals for the Second Circuit
- US Court of Appeals for the Ninth Circuit
- English
